Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population

被引:6
作者
Merino-Ibarra, Erardo
Cenarro, Ana
Martin, Paula
Garcia-Otin, Angel Luis
Goicoechea, Jesus
Guallar, Ana
Calvo, Luisa
Civeira, Fernando
机构
[1] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Med Interna Serv, E-50009 Zaragoza, Spain
[2] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Lab Invest Mol, E-50009 Zaragoza, Spain
[3] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Serv Prevenc Riesgos Laborales, E-50009 Zaragoza, Spain
[4] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Nucl Med Serv, E-50009 Zaragoza, Spain
[5] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Serv Bioquim, E-50009 Zaragoza, Spain
来源
MEDICINA CLINICA | 2007年 / 128卷 / 05期
关键词
metabolic syndrome; insulin resistance; HOMA; waist circumference; diagnosis;
D O I
10.1157/13098390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: Metabolic syndrome (MS) is an abdominal obesity and insulin resistance (IR)-related syndrome associated with a high cardiovascular risk. Recently, the International Diabetes Federation (IDF) has proposed a modification of the Adult Treatment Panel (ATP III) diagnostic criteria. However, the sensitivity of these new criteria has not been established. The aim of the present study was to define the sensitivity and specificity of the different criteria used for the diagnosis of the MS in our population. SUBJECTS AND METHOD: We studied in 177 healthy subjects, 68 men and 109 women, the body mass index, waist circumference (WC), blood pressure, glucose, insulin, lipids and apolipoproteins A1 and B. The HOMA index was used as an IR indicator. IR was considered with an HOMA index >=. 3.8. RESULTS: Subjects with IR showed higher age, systolic blood pressure, triglycerides and apo B, and lower HDL cholesterol. A WC >= 102 cm in men and >= 88 cm in women (ATP III criteria) had a low sensitivity for IR (29.4% and 44.7% respectively), with high specificity (81% and 90%). A WC >= 94 cm in men and >= 80 cm in women (IDF criteria) showed good sensitivity (73.5% and 73.7% respectively) but less specificity (57.1% and 53.3%). The IDF criteria showed better sensitivity than ATP III, without substantial change in the specificity for the different HOMA cut-off points. CONCLUSIONS: ATP III criteria had low sensitivity in our population. The new criteria [WC >= 94 cm in men and >= 80 cm in women, and blood glucose >= 100 mg/dL) improve three-fold the diagnostic sensitivity and, therefore, seems to be more useful for detecting IR in our country.
引用
收藏
页码:168 / 171
页数:4
相关论文
共 21 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[5]   Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population [J].
Ascaso, JF ;
Romero, P ;
Real, JT ;
Priego, A ;
Valdecabres, C ;
Carmena, R .
MEDICINA CLINICA, 2001, 117 (14) :530-533
[6]   Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels [J].
Bairaktari, E ;
Hatzidimou, K ;
Tzallas, C ;
Vini, M ;
Katsaraki, A ;
Tselepis, A ;
Elisaf, M ;
Tsolas, O .
CLINICAL BIOCHEMISTRY, 2000, 33 (07) :549-555
[7]  
Balkau B, 1999, DIABETIC MED, V16, P442
[8]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428